CN Patent

CN1346274A — 含睾酮十一酸酯和蓖麻油的制剂

Assigned to Merck Sharp and Dohme BV · Expires 2002-04-24 · 24y expired

What this patent protects

本发明公开了一种用于口服给药的胶囊形式的药物制剂,其包含作为活性成分的溶于药物上可接受的液体载体中的睾酮十一酸酯,其特征在于液体载体含有至少50%(按重量计)的蓖麻油。选择蓖麻油作为液体载体同时选择睾酮十一酸酯作为雄激素有利于含有约200－250mg/mlTU的溶液。对于任何可口服给药的睾酮溶液来说,这是一项新成果。溶液中还可以含有亲脂性表面活性剂,如丙二醇单月桂酸酯。

USPTO Abstract

本发明公开了一种用于口服给药的胶囊形式的药物制剂,其包含作为活性成分的溶于药物上可接受的液体载体中的睾酮十一酸酯,其特征在于液体载体含有至少50%(按重量计)的蓖麻油。选择蓖麻油作为液体载体同时选择睾酮十一酸酯作为雄激素有利于含有约200－250mg/mlTU的溶液。对于任何可口服给药的睾酮溶液来说,这是一项新成果。溶液中还可以含有亲脂性表面活性剂,如丙二醇单月桂酸酯。

Drugs covered by this patent

Patent Metadata

Patent number
CN1346274A
Jurisdiction
CN
Classification
—
Expires
2002-04-24
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.